Literature DB >> 35418504

Innate and Adaptive Immunity in Noninfectious Granulomatous Lung Disease.

Amy S McKee1,2, Shaikh M Atif1, Michael T Falta1, Andrew P Fontenot3,2.   

Abstract

Sarcoidosis and chronic beryllium disease are noninfectious lung diseases that are characterized by the presence of noncaseating granulomatous inflammation. Chronic beryllium disease is caused by occupational exposure to beryllium containing particles, whereas the etiology of sarcoidosis is not known. Genetic susceptibility for both diseases is associated with particular MHC class II alleles, and CD4+ T cells are implicated in their pathogenesis. The innate immune system plays a critical role in the initiation of pathogenic CD4+ T cell responses as well as the transition to active lung disease and disease progression. In this review, we highlight recent insights into Ag recognition in chronic beryllium disease and sarcoidosis. In addition, we discuss the current understanding of the dynamic interactions between the innate and adaptive immune systems and their impact on disease pathogenesis.
Copyright © 2022 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35418504      PMCID: PMC9106315          DOI: 10.4049/jimmunol.2101159

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  153 in total

1.  Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant.

Authors:  K Kreiss; M M Mroz; B Zhen; H Wiedemann; B Barna
Journal:  Occup Environ Med       Date:  1997-08       Impact factor: 4.402

Review 2.  Sarcoidosis.

Authors:  Robert P Baughman; Elyse E Lower; Roland M du Bois
Journal:  Lancet       Date:  2003-03-29       Impact factor: 79.321

3.  p38 Mitogen-Activated Protein Kinase in beryllium-induced dendritic cell activation.

Authors:  L Li; Z Huang; M Gillespie; P M Mroz; L A Maier
Journal:  Hum Immunol       Date:  2014-10-22       Impact factor: 2.850

4.  Beryllium-specific CD4+ T cells induced by chemokine neoantigens perpetuate inflammation.

Authors:  Michael T Falta; Jeremy C Crawford; Alex N Tinega; Laurie G Landry; Frances Crawford; Douglas G Mack; Allison K Martin; Shaikh M Atif; Li Li; Radleigh G Santos; Maki Nakayama; John W Kappler; Lisa A Maier; Paul G Thomas; Clemencia Pinilla; Andrew P Fontenot
Journal:  J Clin Invest       Date:  2021-05-03       Impact factor: 14.808

Review 5.  Granulomas in schistosome and mycobacterial infections: a model of local immune responses.

Authors:  Matyas Sandor; Joel V Weinstock; Thomas A Wynn
Journal:  Trends Immunol       Date:  2003-01       Impact factor: 16.687

6.  Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis.

Authors:  Jan Wahlström; Jörn Dengjel; Bengt Persson; Hüseyin Duyar; Hans-Georg Rammensee; Stefan Stevanović; Anders Eklund; Robert Weissert; Johan Grunewald
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

7.  Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis.

Authors:  D Gupta; R Agarwal; A N Aggarwal; S K Jindal
Journal:  Eur Respir J       Date:  2007-05-30       Impact factor: 16.671

8.  Use of third-line therapies in advanced sarcoidosis.

Authors:  Elyse E Lower; Madison Sturdivant; Lisa Grate; Robert P Baughman
Journal:  Clin Exp Rheumatol       Date:  2019-11-20       Impact factor: 4.473

9.  Transcriptomics of bronchoalveolar lavage cells identifies new molecular endotypes of sarcoidosis.

Authors:  Milica Vukmirovic; Xiting Yan; Kevin F Gibson; Mridu Gulati; Jonas C Schupp; Giuseppe DeIuliis; Taylor S Adams; Buqu Hu; Antun Mihaljinec; Tony N Woolard; Heather Lynn; Nkiruka Emeagwali; Erica L Herzog; Edward S Chen; Alison Morris; Joseph K Leader; Yingze Zhang; Joe G N Garcia; Lisa A Maier; Ronald G Collman; Wonder P Drake; Michael J Becich; Harry Hochheiser; Steven R Wisniewski; Panayiotis V Benos; David R Moller; Antje Prasse; Laura L Koth; Naftali Kaminski
Journal:  Eur Respir J       Date:  2021-12-02       Impact factor: 33.795

10.  Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity.

Authors:  Kamar-Sulu N Atretkhany; Ilgiz A Mufazalov; Josefine Dunst; Anna Kuchmiy; Violetta S Gogoleva; David Andruszewski; Marina S Drutskaya; Denise L Faustman; Marius Schwabenland; Marco Prinz; Andrey A Kruglov; Ari Waisman; Sergei A Nedospasov
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.